We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerinus Energy Regulatory News (SENX)

Share Price Information for Serinus Energy (SENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.85
Bid: 2.80
Ask: 2.90
Change: 0.00 (0.00%)
Spread: 0.10 (3.571%)
Open: 2.85
High: 2.85
Low: 2.85
Prev. Close: 2.85
SENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covenant Waivers Received

2 Nov 2020 07:00

RNS Number : 8501D
Serinus Energy PLC
02 November 2020
 

2 November 2020

 

Press Release

Covenant Waivers Received

Jersey, Channel Islands, 2 November 2020 -- Serinus Energy plc ("Serinus", "SEN" or the "Company") (AIM:SENX, WSE:SEN) announces that it has received a formal waiver from the European Development and Reconstruction Bank ("EBRD") in relation to the debt service covenant on its Convertible Loan for the period ending 31 December 2020, together with a waiver to complete the restructuring of the terms and conditions of the Convertible Loan, deferred until 26 February 2021.

About Serinus

Serinus is an international upstream oil and gas exploration and production company that owns and operates projects in Tunisia and Romania.

For further information, please refer to the Serinus website (www.serinusenergy.com) or contact the following:

 

Serinus Energy plc

Jeffrey Auld, Chief Executive Officer

Andrew Fairclough, Chief Financial Officer

Calvin Brackman, Vice President, External Relations & Strategy

+44 208 054 2859

 

 

WH Ireland Limited

(Nominated Adviser and Joint Broker)

Katy Mitchell

Harry Ansell (Broker)

Lydia Zychowska

+44 207 220 1666

 

 

Arden Partners plc

(Joint Broker)

Paul Shackleton / Dan Gee-Summons (Corporate Finance)

Fraser Marshall (Equity Sales)

+44 207 614 5900

 

 

Camarco

(Financial PR - London)Billy CleggOwen Roberts

+44 203 781 8334

 

 

TBT i Wspólnicy

(Financial PR - Warsaw)

Katarzyna Terej

+48 602 214 353

 

Translation: This news release has been translated into Polish from the English original.

Forward-looking Statements This release may contain forward-looking statements made as of the date of this announcement with respect to future activities that either are not or may not be historical facts. Although the Company believes that its expectations reflected in the forward-looking statements are reasonable as of the date hereof, any potential results suggested by such statements involve risk and uncertainties and no assurance can be given that actual results will be consistent with these forward-looking statements. Various factors that could impair or prevent the Company from completing the expected activities on its projects include that the Company's projects experience technical and mechanical problems, there are changes in product prices, failure to obtain regulatory approvals, the state of the national or international monetary, oil and gas, financial , political and economic markets in the jurisdictions where the Company operates and other risks not anticipated by the Company or disclosed in the Company's published material. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties and actual results may vary materially from those expressed in the forward-looking statement. The Company undertakes no obligation to revise or update any forward-looking statements in this announcement to reflect events or circumstances after the date of this announcement, unless required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSWFUFESSEFF
Date   Source Headline
5th Jan 202111:00 amRNSHolding(s) in Company
23rd Dec 202012:15 pmRNSHolding(s) in Company
23rd Dec 202010:16 amRNSHolding(s) in Company
23rd Dec 202010:15 amRNSHolding(s) in Company
22nd Dec 20204:43 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:37 pmRNSPrice Monitoring Extension
22nd Dec 20202:07 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSOperational Update
21st Dec 20204:49 pmRNSHolding(s) in Company
21st Dec 20202:05 pmRNSHolding(s) in Company
21st Dec 20209:25 amRNSHolding(s) in Company
21st Dec 20208:45 amRNSManagement Incentivisation Scheme
21st Dec 20208:30 amRNSAdmission of EBRD Shares
21st Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20203:25 pmRNSHolding(s) in Company
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 202010:52 amRNSHolding(s) in Company
17th Dec 20208:30 amRNSAdmission of Shares
15th Dec 202010:30 amRNSVoting Results from Extraordinary General Meeting
14th Dec 20207:00 amRNSAppointment of Joint Broker
3rd Dec 202011:00 amRNSHolding(s) in Company
27th Nov 20204:21 pmRNSHolding(s) in Company
27th Nov 20204:20 pmRNSHolding(s) in Company
27th Nov 20207:00 amRNSOversubscribed fundraise of USD 21 million
26th Nov 20204:35 pmRNSPlacing to raise approximately USD20 million
26th Nov 20204:30 pmRNSAppointment of Nominated Adviser
13th Nov 20207:00 amRNSInterim Results
2nd Nov 20207:00 amRNSCovenant Waivers Received
22nd Oct 20207:00 amRNSRequest for Arbitration filed
13th Oct 20207:00 amRNSLicence Extension and Amended Work Commitment
7th Oct 20207:00 amRNSIssue of Salary Sacrifice Shares
28th Sep 20207:00 amRNSCovenant Waiver Received
14th Aug 20207:00 amRNSInterim Results for the six months ended 30 June
31st Jul 202010:23 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSIssue of Salary Sacrifice Shares
2nd Jul 20207:00 amRNSSalary and Remuneration Reductions Extended
24th Jun 20207:00 amRNSDeferral of EBRD debt repayment
18th May 20207:00 amRNSIssuance of Stock Options
15th May 20204:05 pmRNSResult of AGM
15th May 20207:00 amRNSInterim Results for the period ended 31 March 2020
27th Apr 20207:00 amRNSReduction of Executive and Director Remuneration
20th Apr 20207:00 amRNSNotice of Annual General Meeting
20th Apr 20207:00 amRNSNotice of Annual General Meeting
1st Apr 20207:00 amRNSAppointment of Chief Operating Officer
27th Mar 20207:00 amRNSCovenant Waiver Received
25th Mar 20207:00 amRNS2019 Annual Financial Report
20th Mar 20207:00 amRNSOperational Update
26th Feb 20207:00 amRNSAppointment of Director
14th Feb 20202:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.